A novel route for valerolactam production in Corynebacterium glutamicum : metabolic engineering and bioprocess optimization
Preprint
Abstract
Valerolactam is a promising bio-based monomer for polyamide synthesis, but microbial production remains limited by inefficient 5-aminovalerate (5AVA) cyclization, by-product formation, and insufficient process optimization. In this study, Corynebacterium glutamicum was engineered for valerolactam production by expression of davBA from Pseudomonas putida and lysP from Escherichia coli , followed by conversion of 5AVA to valerolactam using the recently identified avaC gene from Collinsella intestinalis . Flask cultivations confirmed efficient valerolactam formation with only minor accumulation of the by-products L-lysine, 5AVA, and glutarate. Batch bioreactor experiments showed that higher glucose concentrations increased titers but also promoted by-product accumulation, whereas increasing the dissolved oxygen setpoint from 30% to 50% improved growth and volumetric productivity. Intracellular cofactor analysis revealed declining energy status and shifts in redox balance during production. Based on these findings, carbon-limited fed-batch cultivation at 50% rDO improved production performance, reaching 3.6 g/L valerolactam with a yield of 0.231 g/g and a volumetric productivity of 0.075 g/L/h, while minimizing by-product formation. These results establish AvaC-based C. glutamicum as a promising platform for sustainable valerolactam biosynthesis.Keywords
Funding Information
- The Research Council of Norway (345245)
- Novo Nordisk Foundation (NNF24OC0094177)
This publication has 35 references indexed in Scilit:
- Identification of avaC from Human Gut Microbial Isolates that Converts 5AVA to 2-PiperidoneJournal of Microbiology, 2024
- Dynamic upregulation of the rate-limiting enzyme for valerolactam biosynthesis in Corynebacterium glutamicumMetabolic Engineering, 2023
- Understanding gradients in industrial bioreactorsBiotechnology Advances, 2021
- Progress in the metabolic engineering of bio-based lactams and their ω-amino acids precursorsBiotechnology Advances, 2020
- Modern biopolyamide-based materials: synthesis and modificationPolymer Bulletin, 2019
- A new metabolic route for the fermentative production of 5-aminovalerate from glucose and alternative carbon sourcesBioresource Technology, 2017
- Metabolic engineering of Escherichia coli for the production of four-, five- and six-carbon lactamsMetabolic Engineering, 2017
- Engineering Corynebacterium glutamicum for fast production of l-lysine and l-pipecolic acidApplied Microbiology and Biotechnology, 2016
- Bio‐based production of C2–C6 platform chemicalsBiotechnology and Bioengineering, 2012
- Engineering Corynebacterium glutamicum for the production of pyruvateApplied Microbiology and Biotechnology, 2012